Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
EARLY STAGE
 
My Lists

Arete Therapeutics

3912 Trust Way
Hayward, CA 94545
USA
510-785-7060
Website Company Summary Management Team
Team

Management: James Sabry (President/CEO)E Euan MacIntyre (SVP Drug Discovery);  Randall Whitcomb (Chief Medical Officer)
Advisory board: John E Hamer (Burrill & Company financial consultant)
Company

Business description: Arête Therapeutics Inc. (the “Company”) is discovering and developing ‘first in class’ small molecule drugs directed at novel targets for cardiovascular diseases and inflammation. The Company’s proprietary therapies are directed at a new branch of arachidonic acid metabolism, which is a proven (US $10+B) pathway for therapeutic intervention in a variety of inflammatory diseases. Arête’s technology is based on a portfolio of issued and pending patents resulting from over two decades of research by Dr. Bruce Hammock (Distinguished Professor and Scientific Founder) at the University of California at Davis. The Company has a series of proprietary molecules with preclinical efficacy in various animal models of hypertension, renal and lung inflammation. An IND candidate from this series will be selected in 1H06 for progression into Phase Ia/Ib clinical development in 1H07.
Capital

Rounds: 1
Recent fundings: Nov 2008   May 2007
Capital raised: 67.7M
Last Round: 16.7M
Ownership: Private  
VCs include: Alta PartnersBurrillAndCompanyFrazier Healthcare Partners;  Altitude Life Science Ventures

Last Tweets


 

Last Mentions


Overview
Record updated: Nov 2008
Sector: Biotech
Rounds: 1
Recent fundings: Nov 2008   May 2007
Capital raised: 67.7M
Last Round: 16.7M
Ownership: Private